April 28, 2016

By implementing Ateb's Time My Meds, Pharmacy First members will witness significant, measurable impact on increasing prescription fills and improving quality measures.

April 28, 2016

RxCrossroads, a subsidiary of CVS Health, unveiled plans for significant expansion of its distribution center in Louisville, Ky., the Courier-Journal, a USA Today publication, reported Thursday. Acquired in 2005 by Omnicare and later in 2015 by CVS Health, RxCrossroads offers a portfolio of specialty distribution, pharmacy and patient support services. Anticipating a surge in customer demand, the company has laid out plans for an $11 million building, with $8.7 million in equipment and $600,000 in additional startup costs, the Courier-Journal reported. (Courier-Journal

April 28, 2016

CNBC is reporting that at Express Scripts’ annual client conference, the company announced that it would be looking to partner with retail pharmacies that best maintain patient health in an effort to reduce costs associated with diabetes. 

"Right now, people don't differentiate and don't prefer retailers based on their quality, it's usually just a cost equation," Express Scripts chief medical officer Dr. Steve Miller told CNBC. "We think this is going to be huge in the marketplace, because you're going to be able to get millions of patients higher quality care and lower cost on diabetes." (CNBC)
April 27, 2016

Before she joined Diplomat, Hagerman was an associate professor at the Ferris State University College of Pharmacy with a practice site at Hurley Medical Center.

April 27, 2016

 On Tuesday, the FDA approved Aurobindo’s generic Exforge (amlodipine and valsartan) tablets, and on Wednesday gave its OK to the company’s generic Opana (oxymorphone HCl) and Pepcid AC (famotidine). 

April 27, 2016

Ever since the Federal Register published the final Covered Outpatient Drugs Final Rule (which directs pharmacy Medicaid reimbursement according to the average manufacturer price, or “AMP,” model) on Jan. 21, NACDS has been evaluating the rule and determining appropriate actions.

April 27, 2016

Lorrie Carr will oversee ZappRx’s commercialization efforts as it launches and looks to expand its specialty prescribing and management platform. 

April 26, 2016
SILVER SPRING, Md. — The Food and Drug Administration has approved Exelixis’ Cabometyx (cabozantinib) tablets, the company announced this week. Cabometyx is indicated to treat patients with advanced renal cell carcinoma who have previously received anti-angiogenic treatment.   
April 26, 2016
PrescribeWellness has added five new members to its Pharmacy Advisory Board, the company announced Tuesday. 
April 26, 2016

The researchers are currently conducting a National Health and Medical Research Council study using a combination of these nutraceuticals for depression.

April 26, 2016

A new partnership between the two companies will see development and commercialization of generics with a high technological barrier. 

April 25, 2016

The drug had an estimated market size of about $4.2 billion for the 12 months ending February 2016, according to IMS Health. 

April 25, 2016
The new indication for Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets) will allow it to be used for patients with genotype 1b chronic hepatitis C and compensated cirrhosis. 
April 25, 2016
Miller was most recently an attorney with the DEA’s diversion control area, where she advised the agency on controlled substance listed chemical regulation. 
 
April 25, 2016

Perrigo's new CEO led the company's U.S. Consumer Healthcare business from 2003 to 2006

April 25, 2016

Recently resigned Perrigo chairman and CEO Joseph Papa has joined Valeant Pharmaceuticals as its CEO.

April 25, 2016

The drug is a synthetic androgen available in 100-count bottles of 10-mg tablets. 

April 22, 2016
Allergan on Thursday announced that it had acquired topical dermatology company Topokine Therapeutics, which develops medicine for fat reduction.
April 22, 2016

The clinic initiative follows a successful pilot in 2015, which featured what the chain said was the first oral cancer screening in a pharmacy. 

April 22, 2016
The drug had U.S. sales of about $39 million for the 12 months ended December 2015, according to IMS Health. 
 
April 21, 2016

AbbVie and the University of Chicago announced this week a new five-year collaboration to advance oncology medical research and improve the pace of discovery for both organizations.

April 21, 2016

A new partnership between savings program company Medical Security Card (MSC)’s ScriptSave WellRx and medication management company SinfoníaRx will bring on-demand pharmacist access to users of the savings program’s app.

April 20, 2016

Dr. Reddy’s Laboratories subsidiary Promius Pharma announced Tuesday that its Zembrace SymTouch (sumatriptan injection) is now commercially available in the United Stated. 

April 20, 2016
The once-daily oral therapy had previously been approved as a first-line treatment for specific types of non-small cell lung cancer.